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The pX region of human T lymphotropic virus type I (HTLV-I) is bclicvcd IO be expressed as a conscqucncc ora 2 s~cp splicing. It is conccivablc. 
however. that a donor silt or the ISI splicing and an acccplor siw of the 2nd splicing results in the production of an alkrnativcly spliced mRNA 
which is capable of coding p-l 3 x ‘I’. This possibilhy was examined by amplirying cDNA dcrivcd from HTLV-I’ cells between the 5’ LTR and pX 
region. Bands or2 dilTcrcnt sizes were consisuznlly obscrvcd. Scqucncing of the longer band corresponded to a cDNAdcrivcd rrom a double-spliced 
p,Y mRNA as previously rcportcd. The shorter b;md was derived Corn a single-spliced mRNA. HTLV-I‘ cell lines had both mRNAs 10 a varying 
degree. Expression of ~40’” and p2Ix”” seem to bc well correlated whh a double-spliced and a sin@-spliced mRNA, rcspcclivcly. 
HTLV-I: IUS Gcnc; IW Gcnc; PX Protein; Allcrnalivc splicing 
I. INTRODUCTION 
Human T lymphotropic virus type I (HTLV-I) is a 
human retrovirus which preferentially infects mature 
human T cells, Many lines of research evidence suggest 
its close association with adult T cell leukemia (ATL), 
a unique mature T cell malignancy [l-3], and HTLV-I- 
associated myelopathy/tropical spastic paraparesis 
(HAM/TSP) [4] that is most likely caused by immune 
dysfunction involving T cel!s. HTLV-I has a uniqlle 
sequence termed pX, in addition to gug, pot and en\1 
regions [5]. The pX region encodes 3 different molecules 
p40’““, ~27”” and p_ 1 3 ‘.“‘. The ~40’“” molecule is a traws- 
activator of the HTLV-I LTR [6] as well as a variety of 
cellular genes such as those of IL-2, IL-2R [6], IL-3. 
IL-4, granulocyte-macrophage colony stimulating fac- 
tor [7], and c-jbs [8,9]. The ~27”” molecule is considered 
to be a post-transcriptional trurzs-regulator for HTLV-I 
gene expression [lo,1 11, whereas ~21”“’ shares an 
amino acid sequence identical to that of ~27”” except 
that it lacks the N-terminal 78 amino acids. The biologi- 
cal function of p21x-“’ remains unknown. 
Seiki et al. [12] previously showed that the pX region 
is expressed as a consequence of a 2-step splicing which 
generates the 2. i kilobasc (kb) mRNA. This pX mRNA 
Abbrevicrriurrs: HTLV-I, human T lympholropic virus lypc I; ATL. 
adult T cell leukemia; HAWISP, HTLV-I-associated myclopathyl 
tropical spastic paraparcsis; PBMC. pcriphcral blood mononuclear 
cells; RT, rcvcrsc transcription; PCR, polymcrasc chain reaction; 
ECL, cnhanccd chcmilumincsccnce. 
Corrc.r~orrrf~rrcc arfrlrcss: I-l. Shiku. Dcpartmcnl of Oncology, Naga- 
saki University School oT Mcdicinc, Nagasaki R52, Japan. 
has 2 overlapping open reading frames termed rasl, 
encoding ~40’“” [13-l 61, and ~sl, encoding ~27”’ and 
p2 lx-“’ [ 171. Two AUGs for ~40”‘” and ~27”” arc located 
in the second cxon originating from the 3’ region of the 
pal gene, whereas the AUG for ~21”‘” is located in the 
third exon originating from the pX region. The 2.1 kb 
single mRNA ofpX produces 3 pX molecules. However, 
it is possible that a donor site of the 1st splicing and an 
acceptor site of the 2nd splicing proceeds to the produc- 
tion of an a!ternatively spliced mRNA. Although such 
mRNA cannot code for ~40’“” and ~27”” due to the lack 
of the middle exon, it should be capable of coding for 
p21 ‘-“I. In that case, production of ~21”“’ might be 
independent of the regulation of the other 2 pX mole- 
cules. 
We demqnstrate here that an alternatively spliced 
mRNA does exist in HTLV-I-infected cells, among 
which expression levels of a double-spliced mRNA and 
a single-spliced mRNA of pX vary considerably. 
2. MATERIALS AND METHODS 
2. I . C:J!~.Y mrd ccl1 nrhm 
Six HTLV-I-infcclcd cell lines were used. HUT102 [2]. MT-2 [IS] 
and TL-Su [IL)] have been described previously. Three ccl1 lines, Oka, 
Ish and Kaw. wcrc rcccntly cstablisbcd in our laboratory. In addition. 
MOLT-4 and HL60. an HTLV-I-ncgalivc T cell line. were also uli- 
lized. Peripheral blood mononuclear cells (PBMC) Tram 5 HAM pa- 
tients, 2 healthy HTLV-I carriers and a normal HTLV-I-ncgalivc 
individual were also utilized. HUTl02, MT-2, TL-Su and MOLT-4 
wcrc maintained in RPM1 1640 medium with 10% f’clal calrscrum. and 
Oka, Ish and Kaw wcrc maintained in RPM1 1640 medium with 20% 
rcial calrscrum plus I U/ml recombinant IL-2 (Takcda Pharm. Co.). 
PBMC were isolated from hcparinizd venous blood by density gra- 
dient ccntrifuugation and cultured in RPM1 I640 medium with 20% 
Octal calr serum and I U/ml rccombinimt IL-2 for IO days. 
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Total RNX was prcparcd according to Chomczynski itttd Sacchi 
[20]. Cells wcrc washed twice in phosphate-bun‘cred saline end lyscd 
in solution D consisting of 4 M guunidium thiocyanatc. 25 mhl so- 
dium citrate. pH 7.0,0.5% sarcosyl. 0.1 M 2.mcrcaptocthu:tol. Lysato 
was cxtractcil \vith I.3 vol. of 0.2 M sodium acctatc (pH 4.O)/phcnoll 
chloroform (0.1: 1:O.Z). Alicr extraction, RNA was prccipitatcd by 
adding un cilutil volume or isopropanol. rcsuspcndcd in solution D, 
and rc-prccipitatcd with isopropanol. Alicr washing \vith 755% etha- 
nol. the RNA was dissolved in DEPC-treated distilled Water. Oligonu- 
clcotidc printers and probes were synthesized using an itutontatcd 
DNA synthesizer. Model 3808 DNA Synthesizer (Applied Biosys- 
tcms). 
Amplification or pX mRNA was achicvcd with oligoouclcotidc 
primers dsrived Tram the long terminal rcpcat and pX domain or 
HTLV- I. i.e. pX-I and pX-2. respectively. as shown in Pig. I [‘I]. 
Sin&-stnmd cDNA WIS synthcsizcd with oligo-dT,; primer. Total 
RNA (3 pg) ws dissolved in 50 ~tl of 50 mM Tris-HCI (pH 8.3) 
containing75 mM KCI. 3 mM MgCI- IO mM dithiothrcitol. 6.5 mM 
dATP. dGTP. dCTP. dTTP. 0.5 wz o&o dT,.,. and 200 U of Moloncv 
murinc Icukcmia virus rcvcrsc twnscriplase (BRL). then incubated I‘or 
90 min at 3i’C. 5 ~1 of rcvcrsc transcription products were diluted in 
;I 50 ,ul reaction mixture consisting or IO mM Tris-HCI (pH 8.3). 50 
mM KCI. I .5 mM hlgCI1. all 4 dNTPs (0.2 mM each). 0.001% pclatin. 
0.325 pg pX-I primer and 0.325 yg pX-2 primer. The mixture was 
A 
_ _... 
tlw PO’ ml* I I PX 
EL I EX. 2 EX 3 
-‘-\_,~-~7---~ 
Ex. I 
0 
S’,?llner (WI, : 5’ TACCTGAGGGCCCCAlCCACGCCGG,TGA 3 
~‘D~OI @X.2, : 5’ ACACAGTCTCGAGACACGTAGACTGGGTAT 3 
I?‘abo IpX.LlI’Il : GCClCCCGCCTGTGGTGCClCCT~~ACTGCGlCCGCCGTC 
r.!oboIpXJ’oL) : AGOCICTCCMGAAGCTGCCGGCGCTGCTCTCATCCCGGT 
vobo,pX+X) : TCCCAGGGTllGGACAGAGTCTT 
Fig. I. (A)Gcnomic structure: oT HTLV-I provirus and dortblc-spliced 
mRNA forpXgcnc productsanda putativcsinglc-spliccdmRNA. Sd. 
splice donor sit?; Sit. splice acceptor site. The locution ofthc primers 
used t-or PCR. pX-I and pX-2. arc shown under the gcnotnic structure 
The pX-I scnsc primer wits derived from IIIC R rqion of the long 
tcrminttl repeat domain, and the pX- 2 trntiscnsc primer \vas complc- 
mcntary IO a 5’ scqucncc within IIIC pX domain. (B) Scqucnccs or 
primers ror PCR and oligonuclcotidcs used as probes for Southern 
blot analysis. Three internal scnsc oligonuclcotidc pro&s. pX-LTR. 
pX-POL and pX-PX dcrivcd from the long terminal rcptttt, pnl. nnd 
pXdonGs, rcspcctivcly. wcrc used to dctec~ the amplified pX cDNA. 
hcatcd ill 94W for 5 min. quickly cooled on ice. and supplemented 
with I U or Taq DNA polymcrasc (Pcrkin-Elmer Cctus). Samples 
horn HTLV-I-inf’cctcd cell lines and control lines wcrc subjected to 25 
cycles of amplitication and those Tram HAM patients. HTLV-I 
healthy carriers and the uormal individual to 40 cycles. For scmi- 
quantitation or RT-PCR products. samples obtained alicr 20 cycles 
oramplification wcrc analyzed. Each cycle consisted of 3 steps; dcn;t- 
turation ror I min rtt 94°C primer annealing Tar I min ;II 53°C and 
polymerization ror ? min at 72°C. 
10~1 or RT-PCR products \verc clcctrophorcscd on iI I58 polyacryl- 
amide gel. and trca!cd with an alkaline solution (0.4 N N&H, 0.6 M 
NaCI) prior to transl’cr onto nylon tiltcrs. Filters wcrc prchybridizcd 
in a solution containing 3.0 M tctramcthyl ammoniumchloridc. 50 
mill Tris-HCI (pH 8.0). 2 mM EDTA, 0.1% SDS. 5x Dcnhardt’s 
solution and dcnatttrcd salmon sperm DNA. Sanlplcs wcrc hybridized 
overnight at 58OC in the same bulTcr containing an oligonuclcotidc 
probe htbclcd with [r-“P]ATP (NEN) using polynuclcotidc kinasc 
(Tnkara Shuzo Co.) its shown in Fig. I. Alicr hvbridization. filters 
wcrc washed twice in 2x SSC vvitlt 0.1% SDS for 5 niin at room 
tcmpcraturc. twice in 5x SSC with 0.1% SDS (or I5 min at 58°C. and 
exposed to XAR-5 film (Kodak) I’or IO II at -80°C. 
PCR products wc’rc cloned into pBlucscrip: II SK* vectors (Strate- 
gcnc) and used as scqucnciug tcmplatcs. 40 PCR cycles wcrc pcr- 
Tormcd as prcviouslg described using a pX-I primer containing a 
&rrtrHI site and it pX-2 primer containing an f+oRI site. what is. 
primers pX-I’ and pX-2’. Amplilicd products were clcctrophorcscd on 
:I 15% polyacrylanridc gel and spccilic bands cxtractcd by clcctroclu- 
lion wcrc digcsted \vith fWrH I end /?oRI restriction cnzymcs (BRL). 
then inserted into pblucscript II SK’ vectors. Cloned inserts wcrc 
scqucnccd using IIIC Taq Dye Primer Cycle Scqucncing kit vvith the 
DNA Scqucnccr hlodcl 370A (Applied Biosystcms). 
Wcstcrn blot ;tt:;tlySis t-or p40’,‘*, ~37”’ and ~21”“” proteins Wits 
performed according to the mctbod of Tonbin c: a!. [2!]. Ccl!s v:cic 
lyscd with lysis bull’cr consisting of IO mM Tris-HCI. ptl 7.4. 0.15 hl 
NaCI. 5 mM EDT.% 0.1% SDS. I% Triton X-100. 1% DOC. and I 
mM PMSF and scparatcd by SDS-PAGE under reducing conditions. 
Prolcins wcrc ~IICII clcctropliorctically translizrrcd to a PVDF mcm- 
branc (Immobilon. hlilliporc), prctreatcd with 5% skim-milk (Mori- 
naga. Tokyo) in PBS at 4°C overnight. Artcr prctrcatmcnt. the PVDF 
mcmbranc WIS imubatcd with anti-p-IO”” mAb (Lt4) 1331 or anti- 
p27’“‘lp21”“” pcptidc rabbit antibodies [24] Ibr I h ;II room tcmpur- 
aturc. 
Bands wcrc dulcclcd in ~40’:” by using VECTASTAIN ABC kit 
(Vcclor Laboratories) according to the manufttcturcr’s instructions, 
and by protein Apcroxidasc conjugate (Zymcd) at I:500 dilution Tot 
p27”‘ ilnd p21”‘“‘. Each band was dctcctcd by 111~ ECL (cnhanccd 
chcmilumincsccnaj Dctcction System (Amcrshamj. Tkc mcmbranc 
was cxposcd to XAR-5 film (Kodak) Ibr 30-W s at room tcmpcrature. 
2.6. Qlrrrtrrirrrriw csrimrrc o/’ R-T-PCR pr’odrrc’~.~ mui pX prcmitrs 
RT-PCR products were semi-quantilicd by exposing IIIC filter to an 
imaging plate (BAS-III, Fuji Photo Film Co.) t-or I h ;t(tcr Southern 
blot hybridization, tlrcn the radioactivity ofcaclt band W;LS IncIIsurcd 
using the Bio-lm;!ging Analyzer, BAS 2000 (Fuji Photo Film Co.). 
In order to qu;:ntiTy the amount of pX proteins, the dcnsitomctric 
analysis of autontdiogram was pcrrormcd by using UNIGRAPHY 
UHG-IOI (Uniqu Medical Co.). 
3. RESULTS AND DISC1JSSION 
RNA from HTLV-l-infected cell lixs, PBMCs of 
HAM patients, healthy carriers and a normal control 
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was analyzed by RT-PCR as described in Materials and were also sequenced. All of them comprised the scquen- 
Methods (Fig. I). Using 3 sets of probes as shown in ces from the primer pX-1’ to the end (position 470 in the 
Fig. I, RT-PCR products were Southern-blotted. When HTLV-I genomic sequence) of exon 1 and from the 
probes pX-LTR for exon I and pX-PX for exon 3 were beginning (position 7302) of exon 3 to the primer pX-2’. 
used, 2 major bands were detected essentialiy in all sam- Consequently, it was demonstrated that the whole of 
ples, although the intensity of the 2 bands varied depen- exon 2 was deleted and that the splice donor site of exon 
ding on the samples (Fig. 2A,C). The upper band was I bound directly with the splice acceptor site of cxon 3, 
about 343 bp long corresponding with the double- thus producing a single-spliced pX mRNA. Since exon 
spliced pX mRNA previously reported [21]. The lower 2 comprises only 191 nucleotides (position 4993-5183), 
band was about 150 bp long by comparison with molec- it is not surprising that the single-spliced mRNA has 
ular size markers. When probe pX-POL for exon 2 was been missed by standard Northern blot analysis. 
used, only the upper 343-bp band was detected and HTLV-l-infected ceils seem to have both mRNAs to 
none of the samples showed ihe iower band (Fig. 2B). varying degrees as already shown in Fig. 2. In some cell 
In order to confirm the identity of the upper band and lines, like Oka, the double-spliced mRNA is apparently 
to elucidate the derivation of the lower band, the 2 dominant, whereas in others, such as MT-2 and Ish, the 
components were cloned and sequenced as described in single-spliced mRN.A is more dominant. Alternatively, 
Materials and Methods. The results are summarized in both mRNAs are equally recognizable in HUTl02, TL- 
Fig. 3. The sequence of the upper component comprised Su and Kaw. Variations in pX expression also occurs in 
those from the BarlzHI site to the end (position 5183 in short-term-cultured PBMCs derived from HAM pa- 
the HTLV-I genomic sequence [ 121) of exon 2 and from ticnts and HTLV-I carriers, which indicates that the 
the beginning (position 7302) of exon 3 to the primer presence of the single-spliced mRNA is not restricted to 
px-2’ as shown in Fig. 3A. This sequence was consistent long-term-cultured HTLV-IT cell lines. 
with that of a double-spliced mRNA previously de- Since the double-spliced mRNA is capable of coding 
scribed [l2]. Three clones derived from the lower band for p40’:lx, ~27”” and p2l x-u and the single-spliced 
A 
A 
probe ; pX-LTR 
I3 
““? 5183 ,m n50 
S~GTGGATCCC............-..~CACCATOb 
“..._ 
,... 
. . . 
,._..’ 
/_..’ 
._.. 
. . 
” __._....’ 
-._ ,...‘. 
N!mg.?’ _ +mHI 
I .c 
.pl9Iihp;lpx.l 
Ex. 1 Ea. 2 Ex. 3 
1 
bP 
123456 7 8 9 10 11 12 13 14 15 .*-- 
343=-m, mm- - _.. _YlLI_ - 
C 
probe : px - POL 
b? 123456 7 6 9 10 11 
12 13 14 15 
343rcm . -I) a.- .m--tirr r’.; ’ 
. . . .. 
1501, ObrlD -*aa ISa mm-- w- ‘. 
Probe ; px- PX 
Fig. 2. Southern blot an:ilysis of amplilicd DNA fragments dcrivcd 
from HTLV-I pX mRNA: (lanes l-6) RT-PCR products from the 
following HTLV-I infcctcd ccl1 lines; (I) HUTlO?; (2) MT-2; (3)TL- 
Su: (4) Oka; (5) Ish; (6) Kaw; (I~ncs 7-l I) RT-PCR products rrom 
PBMC of HAM patients; (lanes 12-l 3) from healthy carriers; (lanc 14) 
from an HTLV-I-ncgativc control; (htnc 15) from MOLT-4 cell lint. 
Each SEL was hybridized with 3 probes, i.e. (A) pX-LTR. (B) pX-POL, 
and (C) pX-PX. The cxposurc time was 3 h for Inncs I-6, and IO h 
for lanes 7-15. bp, base pairs; M, molecular size markers. 
393 470 7302 7358 
5’ &ATCCACGC= . . . . - . . . CGCCGTCTA&CCACTTCCC . . . . ..s........ TCTACGTG& 
. . . . 
. . . . 
.-x., ,./w 
.. _..’ 
_,...’ 
,._.‘. 
_..’ 
pmw~x.~. _ _ plmiipx.z 
Ea. 1 EL 3 
1 
Fig. 3. DNA scqucncing of RT-PCR products. Forty PCR cycles wcrc 
pcrrormed on an HUTIOZ silmplc usinga pX-l’scnsc primer conlain- 
ing a &rrttHl site, 5’~GGGGATCCCCATCCACGCCGGTTGA-3’, 
and a pX-2’ aruiscnsc primer conlaining an EcoRl site, 5’.GGGA- 
ATTCAACACGTAGACTGGGTAT-3’. (A) The amplified upper 
band (343 bp) was clcctroclulcd and digcsled whh BurtrHI and EcoRl. 
A B~rnHl site was also present in cxon 2 ofthcdoublc-spliced mRNA. 
thcrcf’orc the longer i7agmcm from Ihr: RurnHI site in cxon 2 to the 
position of the 3’.antiscnse primer. pX-2’. wascloncd inlo pBluescrip1 
II SK+ vectors and scqucnccd. (B) The rmplificd lower band (I 51 bp) 
was clcctroclulcd and digcsrcd with Ilrr~~Hl and f&RI rcslriclion 
cnzymcs. cloned into pBlucscript II SK+ vectors. then scqucnccd as 
dcscribcd in Materials and Mclhods. 
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Reciproce! of dilution of cDNA Reciprocal of dilution of cDNA 
Fig. 4. Semi-quantitation ol’RT-PCR products and Western blot analysis of p4Ol.l’. ~27’~‘and p-l 7 x.“‘. (A) The following 6 HTLV-I’ cell lines wcrc 
analyzed; HUTl02. O; MT-?. e; TL-Su, 0; Oka. p: Ish, A; Kaw, m. Two RT-PCR products atier 20 cycles of amplification wcrc analyzed by 
Southern blotting using the pX-PX probe. The radioactivity of two bands, i.e. 343 bp (a) and I51 bp (b), was mcnsurcd by a Bio-Imaging Analyzer 
and plotted. (PSL corresponds to cpm in Bio-Imaging Analyzer.) Standard curves were drawn by applying a J-fold-diluted cDNA of HUT102 (for 
343 bp bands in Fig. Aa) and MT-2 (for I51 bp bands in Fig. Ab). Since HUT102 cxpresscd the extrerncly high amount orRT-PCR products (343 
bp band), a dilution was started at l:lO. (B) Cell extracts from each cell lint containing 2Opg protein for p40’“‘ and 30,~s for ~27’“’ and p21”“” 
were analyzed by Wcstrrn blotting; (law I) HUTlO?; (law 2) MT-2; (lane 3) TL-Su; (Innc 4) Oka: (iane 5) Ish; (lane 6) Kaw; (lane 7j HL60. 
mRNA only for p21 ‘-“‘, the expression of 2 different p,Y 
mRNAs with that of@‘-encoded proteins should corre- 
late. Two different mRNA were detected by Southern 
blot analysis with a pX-PX probe after 20 cycles of 
RT-PCR. Intensity of bands was measured by the Bio- 
Imaging Analyzer which images and quantitatcs with a 
degree of sensitivity equal to the combined use of auto- 
radiography and scintillation counting. Standard curves 
were drawn by applying a 3-fold-diluted cDNA of 
HUT102 (for 343 bp bands in Fig. 4A(a)) and MT-2 
(for 151 bp bands in Fig. 4A(b)), both of which showed 
the maximal expression of corresponding RT-PCR 
products among examined cell lines. Relative amounts 
of 2 different RT-PCR products of 5 cell lines to 
HUT102 or MT-2 were obtained as shown in Fig. 4A 
and summarized in Table I. The presence of p40’““, 
~27”” and p21x-‘u was confirmed by Western blotting 
with appropriate antibodies (Fig. 4B). Expression of 3 
different proteins in 6 different HTLV-I’ cell lines was 
also measured by UNIGRAPHY and summarized in 
Table I. 
Expression of ~40”” seems to be correlated with that 
144 
of the 343-bp band. On the other hand, expression of 
~21”“” seems to be more associated with that of the 
151-bp, but not the 343-bp bands, whereas ~27”” does 
Table I 
Comparison of IWO dirfcrcnt mRSAs from ~hcpX region with expres- 
sion or p40’.‘“, ~27”’ and p2 I sw 
PCR products HUTlli2 MT-2 TL-Su Oka ISII KilW 
and proteins 
PCR prorlws 
343 bp I000” II 18 3.8 2.5 I 
I51 bp 56* 100 32 0.3 44 3.2 
Prorebrs 
P40 
~27 
P2l 
230** 57 78 90 34 ?I 
0** 204 214 I05 145 I38 
65** 56 6 0 25 3 
*Amounts ol RT-PCR products rclativc to HUT102 (ror 343.bp 
bands) and to MT-2 (ror I5 I-bp bands) w-c cstimntcd in Fig. 4A. 
**Unit (corresponding to the O.D. in UNIGRAPHY UHG-lOI) 
based on the intensity of bands dctcctcd in Wcstcrn blot analysis (See 
Fig. 48). 
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not seem to associate with either. Thus it is possible that 
~21’~“’ is more dependent on the single- rather than the 
double-spliced pX mRNA. 
Inoue et al. [lo] have reported that ~27”” acts as a 
post-transcriptional regulator for the expression and 
replication of HTLV-I. Induction of ~27”” expression 
results in increased expression of gaglpol mRNA, as 
well as that of erlr mRNA, whereas expression of tax/ 
rex mRNA (the double-spliced mRNA of px) is greatly 
suppressed. Despite the fact that ~21”” is a part of the 
~27”” peptide, in their experiments it failed to show a 
similar molecular effect, which leaves the biological 
roles of p21x-“’ to be elucidated. Since the entire p2!‘*“’ 
shares an identical amino acid sequence with the C- 
terminal portion of p27”“, analogous or antagonistic 
molecular functions between the 2 molecules may be 
speculated upon, In fact, rcccnt experimental data sug- 
gest a possible antagonistic role of p21x-“’ against ~27”” 
P51. 
It has yet to be determined whether or not ~27’“” 
regulates both the single- and double-spliced mRNA of 
pX. Shifted expression of p21x”“, independently of 
~40’“” and p27”“, may result in an alteration of the 
molecular regulation of HTLV-I genomes and/or cellu- 
lar genomes. Elucidation of the biological function of 
P21X”” is indispensable for further understanding of 
their relationship. 
Ac/tr’o~~,lcdge/,‘cffls: WC thank Dr. Y. Tanaka for providing anti-p40’,‘” 
mAb (Lt4) and anti~p27”“/p21X”‘1 pcptidc rabbit antibodies, and Dr. 
M. Mori for supplying the HAM patients’ samples. This work was 
supported by Special Coordination Funds from the Science and Tcch- 
no!opy Agency of the J qanese Governmen! and by a grant from the 
Ministry of Health and Welfare of Japan. 
REFERENCES 
[I] Hinuma, Y.. Nagata, K., Hanoka, M.. Nakai, M., Matsumoto, 
T., Kinoshita, K., Shirakawa. S. and Miyoshi, I. (1981) Proc. 
Natl. Acad. Sci. USA 78. 6476-6480. 
[2] Poicsz, B.J., Ruscclti, F.W., Gazdar, A.F., Bunn, P.B., Minna, 
J. and Gallo, R.C. (1980) Proc. Natl. Acad. Sci. USA 77,7415- 
7419. 
[3] Yoshida, M., Miyoshi, 1. and Hinuma, Y. (1982) Proc. Natl. 
Acad. Sci. USA 79, 2031-2035. 
[4] Osame, M., Usuku. K., Izumo. S., Ijiti, N., Amitani. H.. Igate. 
A., Matsumoto. M. and Tara. M. (1986) Lance1 I. 1032-1033. 
[5] Seiki, M.. Hattori. S., Hiravama, Y. and Yoshida. M. (1983) 
161 
[71 
Proc. Natl. Acad. Sci. USA SO, 3618-3622. . 
Yoshida. M. and Sciki, M. (1987) Annu. Rev. fmmunol. 5, 541- 
559. 
[81 
]91 
[iO] 
s 11 
1121 
1131 
]l41 
Miyatake, S.. Sciki, M., Malefiji, R.D., Hcikc. T., Fujisawa, J.. 
Takcbc, Y., Nishida, J., Shromai. J., Yokota, T., Yoshida, M.. 
Arai, K. and Arai, N. (1988) Nucleic Acids Rcs. 16.6547-6566. 
Fujii. M., Sassone-Corsi, P. and Vcrma. I.M. (1988) Proc. Natl. 
Acad. Sci. USA 85.8526-8530. 
Nagata, K.. Ohtani, K., Nakamura, M. and Sugmura, K. (1989) 
J. Virol. 68, 3220-3226. 
moue. J., Yoshida. M.and Seiki, M.jl987) Proc. Natl. Acad. Sci. 
USA 84, 3635-3657. 
Hidaka, M.. Inouc, J., Yoshida, M. and Sciki, M. (1988) EMBO 
J. 7, 519-523. 
Sciki, M., Hikikoshi, A., Taniguchi. T. and Yoshida, M. (1985) 
Science 288. 1532-1534. 
Kiyokawa. T., Sciki, M., Imagawa, K., Shimizu, F. and Yoshida, 
M. (1984) Gann 75, 747-75 i. 
Slamon, D.J., Shimotohno, K.. Clint. M.J., Goldc, D.W. and 
Chen. I.S.Y. (1984) Science 226, 6165. 
[I51 Miwa, M., Shimotohno. K., Hoshino, H., Fujino, M. and Sugi- 
mura. T. (1984) Gann 75, 752-755. 
[I61 LCC. TX Coligan, J.E., Sodroski, J.G., Haseltine, W.A., Sala- 
huddin, S.Z., Wang-Staal, F., Gallo, R.C. and Essex. M. (1984) 
Science 226. 57-61. 
[l71 
[I81 
[l91 
[201 
[‘!I 
1221 
1231 
v41 
[251 
Kiyakawa, T., Sciki. M., iwashita, S.. Imayawa, K., Shimizu, F. 
and Yoshida. M. (1985) Proc. Nati. Acad. Sci. USA 82. 8359- 
8363. 
Miyoshi. I., Kubonishi, I.: Yoshimoto,S.. Akagi.T., Ohtsuki, Y., 
Shiraishi. Y.. Naaata. K. and Hinuma. Y. (1981) Nature 294. 
770-771: - 
Gotoh, Y., Sugamura, K. and Hinuma, Y. (1982) Proc. Natl. 
Acad. Sci. USA 79, 4780-4782. 
Chomczynski. P. and Sacchi. N. (1987) Analyt. Biochcm. 162. 
156-l 59. 
Tend!er. C.L., Grecnbcrg, S.J., Blattncr. W.A., Manns. A., 
Murphy, E., Fleishcr, T.. Hanchard, B., Morgan. 0.. Burton, 
J.D., Nelson, D.L. and Waldn1ann.T.A. (1990) Proc. Natl. Acad. 
Sci. USA 87, 5218-5222. 
Towbin, H., Stachclin, T. and Gordon, J. (1979) Proc. Natl. 
Acad. Sci. USA 76.43504354. 
Lee. B., Tanaka, Y. and Tozawa, H. (1989) Tohoku J. Exp. Med. 
157. I-II. 
Siomi, H., Shida, H., Nam, S.H., Nosaka, T., Maki, M. and 
Hatanaka. M. (1988) Cell 55. 197-209. 
Akayama, H., Nosaka, T., Adachi, Y.. Sate. T.. Maki. M. and 
Hatanaka, M. (1991) Proc. 64th Meeting Jpn. Biochcm. Sot. 
145 
